be_ixf;ym_202604 d_05; ct_50
NYSE:SPR charts & data provided by TradingView

Latest Insights on SPR

The strong dollar can help you turbocharge a revenue-producing asset play. It's a play you should consider making … before it’s too late. Time Is Running Out to Turbocharge Your Investments November 20, 2017 by Ted Bauman Currency, Global Economy There's a way to turbocharge a revenue-producing asset play. It's a play you should consider making … before it’s too late.
Why Fidelity National is Setting Up for its Next Leg Higher November 15, 2017 by Optin Pivotal Point Trader The financial services sector is in the midst of a digital transformation. With 20,000 clients worldwide and 27 billion transactions processed, Fidelity National Information Services (FIS) is in a unique position to capitalize. Its business and share price have reached a pivotal point of inflection, which is why we put them in our Pivotal Point Trader portfolio last week. […]
Trade Alert: Time to Book Another 50% Plus Gain November 9, 2017 by Optin Adventure Capitalist We’ve booked our fair share of 50%-plus winners in 2017: Glu Mobile (GLUU) +81%, Camtek (CAMT) +50% and Encana (ECA) +83%. (Myers Industries (MYE) didn’t make the 50% and above cut, but it still landed us a +40% gain.) Today, let’s add another one to our list … I recommended AeroVironment (AVAV) in this year’s April issue. AeroVironment makes small unmanned aircraft systems, advanced development […]
Allocating part of your portfolio to this proven, time-based strategy is essential. You're practically guaranteed to beat the market. What’s The Stock Market? S&P500 & More Explained November 6, 2017 by Ted Bauman Trading Strategies Allocating part of your portfolio to this proven, time-based strategy is essential. You're practically guaranteed to beat the market.
If tests on animals continue to be successful, gene editing could be the long-awaited cure for cancer, AIDS and many other diseases. Gene Editing: The Cure for Every Disease? November 2, 2017 by Ian Dyer Investment Opportunities If tests on animals continue to be successful, gene editing could be the long-awaited cure for cancer, AIDS and many other diseases.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“At the end of August [2018], my 401K was $659,000. Now, on September 4th [2018], it’s $715,000. My account is up $56,000 in the last 5 days!”

- Warren O

“I'm very Happy with your services. I hope you don't plan to retire any time soon! My retirement portfolio depends on your expert guidance. Keep up the great work! Thanks.”

- Randy

"Since I started following your secret over your multiple publications, my $659,000 account is up to $715,000 in just 2 months. I’m up $56,000 in one month alone."

- Will O.

Share This